Sionna Therapeutics, Inc. Common Stock SION Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $65.56M+7.9% | $60.26M+5.2% | $59.35M— | $67.89M— | $60.74M— | ||
| $33.36M+104% | $28.72M+116% | $24.16M— | $19.8M— | $16.33M— | ||
| $98.92M+28.4% | $88.98M+26.1% | $83.5M— | $87.68M— | $77.07M— | ||
| $98.92M+28.4% | $88.98M+26.1% | $83.5M— | $87.68M— | $77.07M— | ||
| -$98.92M-28.4% | -$88.98M-26.1% | -$83.5M— | -$87.68M— | -$77.07M— | ||
| $13.12M+30.7% | $13.3M+62.7% | $12.24M— | $11.14M— | $10.04M— | ||
| $13.36M+24.3% | $13.71M+54.6% | $12.83M— | $11.84M— | $10.75M— | ||
| -$85.57M-29.0% | -$75.27M-22.0% | -$70.68M— | -$75.84M— | -$66.32M— | ||
| -$411.51+84.9% | -$411.53+93.7% | -$414.26— | -$419.47— | -$2,719.47— | ||
| -$411.51+84.9% | -$411.53+93.7% | -$414.26— | -$419.47— | -$2,719.47— | ||
| 129.2M+270% | 110.9M+1,227% | 74.8M— | 35M— | 34.9M— | ||
| 129.2M+270% | 110.9M+1,227% | 74.8M— | 35M— | 34.9M— | ||
| -$85.95M-30.2% | -$75.1M-22.5% | -$71.03M— | -$75.5M— | -$66.01M— | ||
| $242K-65.8% | $419K-40.0% | $585K— | $704K— | $707K— | ||
| -$98.92M-28.4% | -$88.98M-26.1% | -$83.5M— | -$87.68M— | -$77.07M— | ||
| -$98.42M-28.9% | -$88.47M-26.7% | -$82.98M— | -$87.06M— | -$76.34M— | ||
| -$98.42M-28.9% | -$88.47M-26.7% | -$82.98M— | -$87.06M— | -$76.34M— | ||
| -$98.92M-28.4% | -$88.98M-26.1% | -$83.5M— | -$87.68M— | -$77.07M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Sionna Therapeutics, Inc. Common Stock's income statement data come from?
- Every line is extracted from Sionna Therapeutics, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.